scholarly journals The splice 1 variant of HTLV-1 bZIP factor stabilizes c-Jun

Virology ◽  
2020 ◽  
Vol 549 ◽  
pp. 51-58
Author(s):  
Nicholas Polakowski ◽  
Martin Pearce ◽  
Oppah Kuguyo ◽  
Georgina Boateng ◽  
Kimson Hoang ◽  
...  
Keyword(s):  
2017 ◽  
Vol 13 (1) ◽  
pp. e1006120 ◽  
Author(s):  
Haruka Kinosada ◽  
Jun-ichirou Yasunaga ◽  
Kazuya Shimura ◽  
Paola Miyazato ◽  
Chiho Onishi ◽  
...  

Retrovirology ◽  
2011 ◽  
Vol 8 (S1) ◽  
Author(s):  
Nanae Taguchi ◽  
Yorifumi Satou ◽  
Koichi Ohshima ◽  
Masao Matsuoka
Keyword(s):  

Retrovirology ◽  
2011 ◽  
Vol 8 (1) ◽  
pp. 19 ◽  
Author(s):  
Keita Hagiya ◽  
Jun-ichirou Yasunaga ◽  
Yorifumi Satou ◽  
Koichi Ohshima ◽  
Masao Matsuoka

Saúde com ◽  
2018 ◽  
Vol 14 (4) ◽  
Author(s):  
Caroline Rocha ◽  
Fernanda Barreto
Keyword(s):  

A proteína HTLV-1 bzip factor (HBZ) é produzida pelas células infectadas pelo HTLV-1 e sua expressão se dá de forma constante em células de indivíduos com Leucemia/Linfoma de Células T do Adulto (ATLL). Essa patologia é grave e, apesar de existir tratamentos que reduzam os sintomas e aumentem a sobrevida do paciente, ainda não existe cura conhecida para a infecção pelo HTLV-1. A HBZ foi descrita como uma das principais proteínas virais que induzem proliferação e imortalização celular da célula infectada pelo HTLV-1. Como a HBZ é sempre expressa em células de pacientes com ATLL, é importante discutir os mecanismos de atuação dessa proteína para auxiliar estudos futuros sobre tratamento e prevenção de doenças provocadas pelo HTLV-1. Portanto, esse trabalho possui como objetivo principal investigar as vias de atuação dessa proteína no desenvolvimento da ATLL. Essa revisão sistemática foi realizada a partir de artigos encontrados na plataforma de busca do PubMed. Foram encontrados 61 artigos, destes 20 foram incluídos e seus dados foram coletados. A partir dos dados obtidos, é possível concluir que proteína HBZ é importante no desenvolvimento de ATLL ao contribuir na proliferação, imortalização e sobrevivência das células infectadas. Porém ainda não está claro se a HBZ participa do mecanismo inicial de desenvolvimento da ATLL.


Retrovirology ◽  
2014 ◽  
Vol 11 (Suppl 1) ◽  
pp. O43 ◽  
Author(s):  
Céline Vernin ◽  
Christiane Pinatel ◽  
Antoine Gessain ◽  
Olivier Gout ◽  
Marie-Hélène Delfau-Larue ◽  
...  

2013 ◽  
Vol 9 (9) ◽  
pp. e1003630 ◽  
Author(s):  
Nanae Yamamoto-Taguchi ◽  
Yorifumi Satou ◽  
Paola Miyazato ◽  
Koichi Ohshima ◽  
Masanori Nakagawa ◽  
...  
Keyword(s):  

1999 ◽  
Vol 19 (2) ◽  
pp. 173-181 ◽  
Author(s):  
R. Steven Conlan ◽  
Michael Hammond-Kosack ◽  
Michael Bevan

Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 2405-2405
Author(s):  
Jun-ichirou Yasunaga ◽  
Guangyong Ma ◽  
Jun Fan ◽  
Masao Matsuoka

Abstract Abstract 2405 Adult T-cell leukemia (ATL) is a fatal malignancy of CD4-positive T-cells caused by human T-cell leukemia virus type1 (HTLV-1). HTLV-1 bZIP factor (HBZ) is encoded in the minus strand of HTLV-1 provirus, and is consistently expressed in HTLV-1-infected cells. It has been shown that HBZ promotes proliferation of T-cells, and HBZ-expressing transgenic mice develop T-cell lymphomas and systemic inflammations, suggesting that HBZ has the critical roles in pathogenesis of HTLV-1. However, the molecular mechanisms of HBZ-induced oncogenesis have not been clarified yet. The Wnt signaling is a highly conserved cellular signaling pathway in eukaryotes and the Wnt ligands have been found to trigger multiple pathways of Wnt signaling. The most well-studied cascade is the Wnt/β-catenin pathway (also known as the canonical Wnt pathway), which is β-catenin-dependent and mainly controls cell differentiation, proliferation, and apoptosis. Aberrant activation of the canonical Wnt pathway has been linked to many cancers. In contrast, it is known that the noncanonical Wnt pathway antagonizes the canonical pathway, while a representative noncanonical Wnt ligand, Wnt5a, is suggested to have both oncogenic and tumor suppressive properties in several malignancies. The significance of those Wnt pathways in HTLV-1-associated oncogenesis is still obscure. In this study, we found that HBZ markedly suppressed the canonical Wnt/β-catenin pathway. As a mechanism of HBZ-mediated Wnt suppression, we found that HBZ targets LEF1 and TCF1, the key transcription factors of the pathway, and impairs its DNA-binding ability. In contrast, HTLV-1 Tax protein interacted with Dvl and DAPLE, which are the regulators of the canonical Wnt signaling, and activated the pathway. Indeed, the canonical Wnt activation is not observed in ATL cells, and enforced activation of β-catenin in ATL cells inhibited cellular proliferation, implying that activation of the canonical Wnt pathway might have suppressive effect on ATL cells. On the other hand, HBZ induces the transcription of the noncanonical Wnt5a by enhancing its promoter activity. In addition, Wnt5a transcription level in ATL cells is significantly higher than in HTLV-1-uninifected control cells. Knockdown of Wnt5a impairs both proliferation and migration of ATL cells, suggesting that HBZ-induced Wnt5a supports development and progression of ATL. Our results implicate novel roles of HBZ in ATL leukemogenesis through dysregulation of both the canonical and noncanonical Wnt pathways. Disclosures: No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document